Contact this trialFirst, we need to learn more about you.
Direct Oral Anticoagulant
Apixaban for Heart Failure with LVAD Implant
Recruiting1 awardPhase 2
Falls Church, Virginia
This trial is comparing two blood-thinning medications, apixaban and warfarin, in patients with a specific heart device called HeartMate 3 LVAD. These medications help prevent blood clots, which is crucial for these patients. Apixaban has been shown to be a safe and effective alternative to warfarin for stroke prevention in various patient populations, including those with atrial fibrillation.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service